Literature DB >> 17220373

Protective effect of orally administered carnosine on bleomycin-induced lung injury.

Salvatore Cuzzocrea1, Tiziana Genovese, Marco Failla, Graziella Vecchio, Mary Fruciano, Emanuela Mazzon, Rosanna Di Paola, Carmelo Muià, Cristina La Rosa, Nunzio Crimi, Enrico Rizzarelli, Carlo Vancheri.   

Abstract

Carnosine is an endogenously synthesized dipeptide composed of beta-alanine and L-histidine. It acts as a free radical scavenger and possesses antioxidant properties. Carnosine reduces proinflammatory and profibrotic cytokines such as transforming growth factor-beta (TGF-beta), IL-1, and TNF-alpha in different experimental settings. In the present study, we investigated the efficacy of carnosine on the animal model of bleomycin-induced lung injury. Mice were subjected to intratracheal administration of bleomycin and were assigned to receive carnosine daily by an oral bolus of 150 mg/kg. One week after fibrosis induction, bronchoalveolar lavage (BAL) cell counts and TGF-beta levels, lung histology, and immunohistochemical analyses for myeloperoxidase, TGF-beta, inducible nitric oxide synthase, nitrotyrosine, and poly(ADP-ribose) polymerase were performed. Finally, apoptosis was quantified by terminal deoxynucleotidyltransferase-mediated UTP end-labeling assay. After bleomycin administration, carnosine-treated mice exhibited a reduced degree of lung damage and inflammation compared with wild-type mice, as shown by the reduction of 1) body weight, 2) mortality rate, 3) lung infiltration by neutrophils (myeloperoxidase activity and BAL total and differential cell counts), 4) lung edema, 5) histological evidence of lung injury and collagen deposition, 6) lung myeloperoxidase, TGF-beta, inducible nitric oxide synthase, nitrotyrosine, and poly(ADP-ribose) polymerase immunostaining, 7) BAL TGF-beta levels, and 8) apoptosis. Our results indicate that orally administered carnosine is able to prevent bleomycin-induced lung injury likely through its direct antioxidant properties. Carnosine is already available for human use. It might prove useful as an add-on therapy for the treatment of fibrotic disorders of the lung where oxidative stress plays a role, such as for idiopathic pulmonary fibrosis, a disease that still represents a major challenge to medical treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220373     DOI: 10.1152/ajplung.00283.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  21 in total

1.  A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.

Authors:  J S Swaney; C Chapman; L D Correa; K J Stebbins; R A Bundey; P C Prodanovich; P Fagan; C S Baccei; A M Santini; J H Hutchinson; T J Seiders; T A Parr; P Prasit; J F Evans; D S Lorrain
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFγ-induced oxidative stress.

Authors:  Vittoria Spina-Purrello; Salvatrice Giliberto; Vincenza Barresi; Vincenzo G Nicoletti; Anna Maria Giuffrida Stella; Enrico Rizzarelli
Journal:  Neurochem Res       Date:  2010-10-30       Impact factor: 3.996

3.  MEK inhibition suppresses the development of lung fibrosis in the bleomycin model.

Authors:  Maria Galuppo; Emanuela Esposito; Emanuela Mazzon; Rosanna Di Paola; Irene Paterniti; Daniela Impellizzeri; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

4.  D-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation.

Authors:  Stefano Menini; Carla Iacobini; Carlo Ricci; Angela Scipioni; Claudia Blasetti Fantauzzi; Andrea Giaccari; Enrica Salomone; Renato Canevotti; Annunziata Lapolla; Marica Orioli; Giancarlo Aldini; Giuseppe Pugliese
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

5.  The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae.

Authors:  Daniel Drömann; Jan Rupp; Kristina Rohmann; Sinia Osbahr; Artur J Ulmer; Sebastian Marwitz; Kristina Röschmann; Mahdi Abdullah; Holger Schultz; Ekkehard Vollmer; Peter Zabel; Klaus Dalhoff; Torsten Goldmann
Journal:  Respir Res       Date:  2010-05-31

6.  Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial.

Authors:  R N Feng; Y C Niu; X W Sun; Q Li; C Zhao; C Wang; F C Guo; C H Sun; Y Li
Journal:  Diabetologia       Date:  2013-01-30       Impact factor: 10.122

7.  FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice.

Authors:  Carla Iacobini; Stefano Menini; Claudia Blasetti Fantauzzi; Carlo M Pesce; Andrea Giaccari; Enrica Salomone; Annunziata Lapolla; Marica Orioli; Giancarlo Aldini; Giuseppe Pugliese
Journal:  Br J Pharmacol       Date:  2017-12-08       Impact factor: 8.739

8.  Sex differences in the acute in vivo effects of different human SP-A variants on the mouse alveolar macrophage proteome.

Authors:  David S Phelps; Todd M Umstead; Joanna Floros
Journal:  J Proteomics       Date:  2014-06-18       Impact factor: 4.044

9.  Nutritional Interventions for COVID-19: A Role for Carnosine?

Authors:  Jack Feehan; Maximilian de Courten; Vasso Apostolopoulos; Barbora de Courten
Journal:  Nutrients       Date:  2021-04-26       Impact factor: 5.717

10.  Anti-stress effects of carnosine on restraint-evoked immunocompromise in mice through spleen lymphocyte number maintenance.

Authors:  Yi-Fang Li; Rong-Rong He; Bun Tsoi; Xiao-Di Li; Wei-Xi Li; Keiichi Abe; Hiroshi Kurihara
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.